NovaBridge Biosciences (NBP) › Shareholders' EquityNovaBridge Biosciences (NBP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -14.51M CNY2017: -299.80M CNY2018: -955.10M CNY2019: -2.03B CNY2020: 5.63B CNY2021: 4.56B CNY2022: 2.91B CNY2023: 1.72B CNY1.72B CNY2016Shareholders' Equity (CNY)2023Fiscal YearShareholders' EquityChange YoY20231.72B CNY-41.0%20222.91B CNY-36.2%20214.56B CNY-19.0%20205.63B CNY+376.6%2019-2.03B CNY-113.0%2018-955.10M CNY-218.6%2017-299.80M CNY-1965.8%2016-14.51M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share